{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T09:30:43Z","timestamp":1793784643347,"version":"4.6.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK129431-01A1"],"award-info":[{"award-number":["R01DK129431-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bbrc.2026.154740","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:44:41Z","timestamp":1791906281000},"page":"154740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Acute FGF23 neutralization alters phosphate handling and bone marrow molecular responses in sickle cell disease mice"],"prefix":"10.1016","volume":"839","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9763-3001","authenticated-orcid":false,"given":"Liping","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5569-6901","authenticated-orcid":false,"given":"Vanessa M.","family":"Scanlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2866-4242","authenticated-orcid":false,"given":"Marja M.","family":"Hurley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.154740_bib1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-pathmechdis-012418-012838","article-title":"Pathophysiology of sickle cell disease","volume":"14","author":"Sundd","year":"2019","journal-title":"Annu. Rev. Pathol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154740_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41581-019-0189-5","article-title":"FGF23 at the crossroads of phosphate, iron economy and erythropoiesis","volume":"16","author":"Edmonston","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"issue":"11","key":"10.1016\/j.bbrc.2026.154740_bib3","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154740_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ki.2015.290","article-title":"Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production","volume":"89","author":"David","year":"2016","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154740_bib5","article-title":"Fibroblast growth factor 23 neutralizing antibody partially rescues bone loss and increases hematocrit in sickle cell disease mice","volume":"15","author":"Xiao","year":"2025","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154740_bib6","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1182\/blood-2006-02-004812","article-title":"Correction of sickle cell disease by homologous recombination in embryonic stem cells","volume":"108","author":"Wu","year":"2006","journal-title":"Blood"},{"issue":"5339","key":"10.1016\/j.bbrc.2026.154740_bib7","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1126\/science.278.5339.873","article-title":"Knockout-transgenic mouse model of sickle cell disease","volume":"278","author":"Ryan","year":"1997","journal-title":"Science"},{"issue":"16","key":"10.1016\/j.bbrc.2026.154740_bib8","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1111\/bph.15193","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"177","author":"Percie du Sert","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.bbrc.2026.154740_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.bbrc.2026.154740_bib10","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/jbmr.3417","article-title":"FGF23 neutralizing antibody partially improves bone mineralization defect of HMWFGF2 isoforms in transgenic female mice","volume":"33","author":"Xiao","year":"2018","journal-title":"J. Bone Miner. Res."},{"issue":"9","key":"10.1016\/j.bbrc.2026.154740_bib11","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1002\/jcb.25493","article-title":"FGFR inhibitor ameliorates hypophosphatemia and impaired Engrailed-1\/Wnt signaling in FGF2 high molecular weight isoform transgenic mice","volume":"117","author":"Du","year":"2016","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbrc.2026.154740_bib12","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3389\/fphys.2019.00304","article-title":"The EPO-FGF23 signaling pathway in erythroid progenitor cells: opening a new area of research","volume":"10","author":"van Vuren","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbrc.2026.154740_bib13","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2025030634","article-title":"Erythroid-produced intact FGF23 is a paracrine inhibitor of erythropoiesis","author":"Courbon","year":"2026","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2026.154740_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2026.06.026","article-title":"Role of erythroid fibroblast growth factor 23 in regulating erythropoiesis","author":"Drueke","year":"2026","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154740_bib15","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.bcmd.2015.07.010","article-title":"Erythropoietic drive is the strongest predictor of hepcidin level in adults with sickle cell disease","volume":"55","author":"Karafin","year":"2015","journal-title":"Blood Cells Mol. Dis."},{"issue":"6","key":"10.1016\/j.bbrc.2026.154740_bib16","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/bjh.16498","article-title":"Regulation of iron homeostasis through the erythroferrone-hepcidin axis in sickle cell disease","volume":"189","author":"Mangaonkar","year":"2020","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.bbrc.2026.154740_bib17","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s00223-013-9831-6","article-title":"Effects of extracellular phosphate on gene expression in murine osteoblasts","volume":"94","author":"Rendenbach","year":"2014","journal-title":"Calcif. Tissue Int."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154740_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093840","article-title":"Dysregulated gene expression in the primary osteoblasts and osteocytes isolated from hypophosphatemic Hyp mice","volume":"9","author":"Miyagawa","year":"2014","journal-title":"PLoS One"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26015068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26015068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T09:01:46Z","timestamp":1793782906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26015068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":18,"alternative-id":["S0006291X26015068"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154740","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute FGF23 neutralization alters phosphate handling and bone marrow molecular responses in sickle cell disease mice","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154740","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"154740"}}